Login to Your Account

Cash-Strapped Iomai Jumps on $189M Buyout Bid by Intercell

By Jennifer Boggs and Cormac Sheridan

Wednesday, May 14, 2008
Shares of Iomai Corp. surged more than 117 percent after the firm agreed to be acquired by Austrian vaccines maker Intercell AG in a deal valued at about $189 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription